Stock-Based Awards (Tables)
|
12 Months Ended |
Dec. 31, 2014
|
Share-based Compensation [Abstract] |
|
Stock-Based Compensation Expense |
Stock-based compensation expense is included in the following line items in the accompanying consolidated statements of operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
2014 |
|
2013 |
|
2012 |
Selling and marketing |
|
$ |
4,736 |
|
|
$ |
3,793 |
|
|
$ |
3,515 |
|
General and administrative |
|
10,870 |
|
|
10,250 |
|
|
15,541 |
|
Stock-based compensation expense before income taxes |
|
15,606 |
|
|
14,043 |
|
|
19,056 |
|
Income tax benefit |
|
(5,685 |
) |
|
(4,835 |
) |
|
(6,494 |
) |
Stock-based compensation expense after income taxes |
|
$ |
9,921 |
|
|
$ |
9,208 |
|
|
$ |
12,562 |
|
|
|
|
|
|
|
|
|
Summary Of Status Of Nonvested RSUs |
A summary of the status of the nonvested RSUs, as of December 31, 2014 and changes during the year ended December 31, 2014 is as follows:
|
|
|
|
|
|
|
|
|
|
|
Number of
RSUs
|
|
Weighted
Average Grant
Date Fair Value
|
Nonvested at January 1, 2014 |
|
623,709 |
|
|
$ |
40.25 |
|
Granted |
|
238,620 |
|
|
55.06 |
|
Vested |
|
(191,106 |
) |
|
29.18 |
|
Forfeited |
|
(69,644 |
) |
|
47.62 |
|
Nonvested at December 31, 2014 |
|
601,579 |
|
|
48.88 |
|
|
Summary Of Status Of Outstanding Stock Options And SARs |
A summary of the status of the outstanding stock options and SARs as of December 31, 2014 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
options
|
|
Weighted
Average
Exercise Price
|
|
Weighted
Average
Remaining
Contractual
Term (in years)
|
|
Aggregate
Intrinsic Value
|
Outstanding at January 1, 2014 |
|
2,580,889 |
|
|
$ |
34.15 |
|
|
|
|
|
Granted |
|
423,579 |
|
|
55.05 |
|
|
|
|
|
Exercised |
|
(650,740 |
) |
|
24.34 |
|
|
|
|
|
Forfeited |
|
(39,528 |
) |
|
54.70 |
|
|
|
|
|
Expired |
|
(17,520 |
) |
|
17.63 |
|
|
|
|
|
Outstanding at December 31, 2014 (1) |
|
2,296,680 |
|
|
40.54 |
|
|
5.3 |
|
$ |
81,429,314 |
|
Vested and expected to vest at December 31, 2014 |
|
2,223,860 |
|
|
40.04 |
|
|
5.2 |
|
$ |
79,976,327 |
|
Exercisable at December 31, 2014 |
|
1,598,089 |
|
|
35.07 |
|
|
3.9 |
|
$ |
65,406,938 |
|
|
|
(1) |
Approximately 0.3 million stock options outstanding as of December 31, 2014 were held by employees of the other Spincos.
|
|
Weighted Average Assumptions Used In Black-Scholes Option Pricing Model |
The weighted average assumptions used in the Black-Scholes option pricing model are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2014 |
|
2013 |
|
2012 |
Volatility factor |
|
36.4 |
% |
|
49.1 |
% |
|
46.5 |
% |
Risk-free interest rate |
|
1.55 |
% |
|
0.85 |
% |
|
0.91 |
% |
Expected term |
|
4.7 |
|
|
4.8 |
|
|
5.0 |
|
Dividend yield |
|
1.8 |
% |
|
1.2 |
% |
|
1.4 |
% |
|
Summary Of Information About Stock Options And SARs Outstanding And Exercisable |
The following table summarizes the information about stock options and SARs outstanding and exercisable as of December 31, 2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding |
|
Exercisable |
|
|
Number
Outstanding at
December 31,
2014
|
|
Weighted
Average
Exercise Price
|
|
Weighted
Average
Remaining
Contractual
Term in Years
|
|
Number
Exercisable at
December 31,
2014
|
|
Weighted
Average
Exercise Price
|
$0.00 to $9.99 |
|
96,094 |
|
|
$ |
5.65 |
|
|
4.0 |
|
96,094 |
|
|
$ |
5.65 |
|
$10.00 to $19.99 |
|
136,836 |
|
|
17.74 |
|
|
3.7 |
|
136,836 |
|
|
17.74 |
|
$20.00 to $29.99 |
|
57,320 |
|
|
29.72 |
|
|
6.1 |
|
57,320 |
|
|
29.72 |
|
$30.00 to $39.99 |
|
959,121 |
|
|
34.92 |
|
|
3.9 |
|
848,201 |
|
|
34.82 |
|
$40.00 to $49.99 |
|
370,555 |
|
|
44.71 |
|
|
3.6 |
|
370,555 |
|
|
44.71 |
|
$50.00 to $59.99 |
|
676,754 |
|
|
56.72 |
|
|
8.7 |
|
89,083 |
|
|
59.19 |
|
|
|
2,296,680 |
|
|
|
|
|
|
1,598,089 |
|
|
|
|
Weighted Average Assumptions Used In Valuation Of ESPP Options |
The following are the weighted average assumptions used in the valuation of the ESPP options for the years ended December 31, 2014 and 2013:
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2014 |
|
2013 |
Volatility factor |
|
22.0 |
% |
|
23.3 |
% |
Risk-free interest rate |
|
0.08 |
% |
|
0.10 |
% |
Expected term |
|
0.5 |
|
|
0.5 |
|
Dividend yield |
|
1.7 |
% |
|
1.3 |
% |
|